Trump administration drug-price deals with pharma include inducements to raise prices abroad and tariff protection, Washington Post reports

The Trump administration's confidential deals with pharmaceutical companies to lower U.S. drug prices include inducements to raise drug prices overseas and promises of protection from tariffs, according to documents shared with The Washington Post, which reported the arrangement exclusively.

Detected & updated continuously · Source: Nebula